Combining cell and gene therapeutic approaches is reshaping basic and translational research, yielding new models and tools that help scientists delve deeper into the drivers of health and disease. However, the complexity of cell and gene therapy (CGT) manufacturing contributes to low trial to approval success rates. As such, scientists and engineers look for ways to improve and streamline CGT production workflows, including using good manufacturing practices (GMP)-grade materials and reagents from well-established and scrutinized sources.
Download this ebook from ACROBiosystems to learn about
- The complexities of quality CGT manufacturing
- How to incorporate GMP-grade raw materials into CGT manufacturing
- The stages of CGT development workflows
- ACROBiosystem’s diverse, GMP-grade reagent portfolio
